Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mecasermin

EU orphan designation number: EU/3/05/307   
Active ingredient: Mecasermin
Indication: Treatment of primary growth hormone insensitivity syndrome
Sponsor: Ipsen Pharma
65 quai Georges Gorse, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Centralised Orphan - Designation EMEA/OD/025/05 (2005)3318 of 26/08/2005
16/12/2005 Centralised Orphan - Transfer of orphan designation EMEA/OD/025/05/T/01 (2005)5628 of 14/12/2005
05/07/2007 Other procedure
15/09/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/025/05/T/02 (2009)7039 of 14/09/2009